Skip to content
Chandra Bhagat Pharma logo

Chandra Bhagat Pharma

542934 BSE
₹57.25

Close ·

View as Markdown
MCP
Close 4 Nov 2026 ₹57.25 +17.24 +43.1% 1Y
Start ₹40.01

Key Fundamentals

SMEPharmaceuticals & BiotechnologyHealthcare

Price-based figures at the close · TTM

ROCE
12.10%
Debt to Equity
0.50
EPS (TTM)
—
Book Value
₹43.90
Market Cap
—
P/E (TTM)
—
P/B
1.30
ROE
9.67%
Dividend Yield
0.00%
EBITDA
₹7.20 Cr
52W High
₹60.06
52W Low
₹29.70

Key Insights

Strengths

3
  • Company has reduced debt.
  • Stock is trading at 0.91 times its book value
  • Promoter holding has increased by 0.83% over last quarter.

Weaknesses

5
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 10.5% over past five years.
  • Company has a low return on equity of 5.92% over last 3 years.
  • Earnings include an other income of Rs.3.35 Cr.
  • Company has high debtors of 171 days.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish4213
OscillatorsBearish423
Moving AveragesStrong Bullish0010

Key readings

RSI (14)
65.86
Neutral
MACD (12,26,9)
3.25
Bullish
SMA (50)
43.13
Bullish
SMA (200)
48.59
Bullish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
10Y+3.79%
5Y+10.32%
3Y−1.12%
1Y+30.34%

Net profit

Net profit growth by window
10YZero base
5YZero base
3Y+44.22%
1Y+200.00%

Operating cash flow

Operating cash flow growth by window
10YZero base
5Y+2.38%
3Y+21.64%
1YTurned positive

Operating margin· change in pp

Operating margin growth by window
10Y−0.30 pp
5Y−2.18 pp
3Y+0.95 pp
1Y+2.33 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹90.00 Cr
Mar 2018₹97.00 Cr
Mar 2019₹106 Cr
Mar 2020₹94.00 Cr
Mar 2021₹71.00 Cr
Mar 2022₹94.00 Cr
Mar 2023₹120 Cr
Mar 2024₹221 Cr
Mar 2025₹89.00 Cr
Mar 2026₹116 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹1.00 Cr
Mar 2018₹1.00 Cr
Mar 2019₹1.00 Cr
Mar 2020₹0.00 Cr
Mar 2021₹0.00 Cr
Mar 2022₹1.00 Cr
Mar 2023₹1.00 Cr
Mar 2024₹2.00 Cr
Mar 2025₹1.00 Cr
Mar 2026₹3.00 Cr

Half-yearly Results

₹ Cr
542934 half-yearly results, ₹ crore
Particulars Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
22
48
43
51
44
75
119
102
65
22
26
91
Expenses
21
47
42
50
43
74
124
104
66
22
24
89
Operating Profit
2
2
2
1
1
2
−5
−2
−1
0
2
2
OPM %
7%
3.4%
3.8%
2.1%
2.3%
2.4%
−4.2%
−2%
−1.8%
−1.2%
7%
2.4%
Other Income
0
0
0
1
1
0
7
4
3
2
0
3
Interest
2
2
1
2
1
1
1
1
1
1
1
1
Depreciation
0
0
0
0
0
0
0
0
0
1
1
0
PBT
0
0
1
1
1
1
1
1
1
1
1
4
Tax %
25%
33%
24%
31%
31%
15%
32%
34%
−11%
69%
22%
26%
Net Profit
0
0
0
0
0
1
1
1
1
0
0
3
EPS (₹)
0.04
0.21
0.57
0.48
0.49
0.72
0.83
1.19
0.9
0.23
0.6
3.45

Profit & Loss

₹ Cr
542934 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
61
80
90
97
106
94
71
94
120
221
89
116
Expenses
58
76
85
92
102
91
67
91
116
228
88
112
Operating Profit
3
3
4
5
5
3
4
3
3
−7
1
4
OPM %
4.9%
4.3%
4.9%
4.7%
4.3%
3.3%
5%
3%
2.8%
−3.2%
0.7%
3.3%
Other Income
0
0
0
1
0
0
0
2
0
11
3
3
Interest
2
3
4
4
4
3
4
3
2
1
2
2
Depreciation
0
0
0
0
0
0
0
0
0
1
1
1
PBT
1
1
1
2
1
0
0
1
1
2
1
4
Tax %
39%
51%
27%
33%
22%
26%
32%
27%
22%
33%
26%
26%
Net Profit
0
0
1
1
1
0
0
1
1
2
1
3
EPS (₹)
1.3
1.06
2
3.12
1.28
0.41
0.25
1.06
1.21
2.03
1.14
4.04
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%

Balance Sheet

₹ Cr
542934 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.42
0.42
0.42
0.42
0.67
8
8
8
8
8
8
8
Reserves
6
6
7
8
14
18
18
19
20
21
22
26
Borrowings
28
28
22
22
31
30
27
21
19
16
21
17
Other Liabilities
8
10
26
28
37
19
19
25
14
56
51
45
Total Liabilities
42
44
56
58
83
75
72
72
61
102
102
94
Fixed Assets
1
1
1
1
0
0
0
0
1
3
3
3
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
5
1
4
1
0
0
0
0
0
2
Other Assets
41
44
51
56
78
74
71
72
60
99
99
90
Total Assets
42
44
56
58
83
75
72
72
61
102
102
94

Cash Flow

₹ Cr
542934 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
0
−9
−6
4
−7
8
12
5
6
−6
9
Investing
0
0
0
0
0
0
0
0
0
−2
−1
0
Financing
0
0
8
7
−4
7
−6
−10
−4
−6
2
−6
Net Cash Flow
0
0
−1
0
0
0
2
3
1
−1
−4
2
Free Cash Flow
0
0
−9
−6
4
−7
8
12
5
4
−6
8
CFO/EBITDA
0
0
−200
−129
98
−238
229
440
164
−94
−805
250

Ratios

542934 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
71
66
80
67
90
54
80
58
25
65
148
171
Inventory Days
177
123
133
145
174
187
215
153
100
15
3
18
Days Payable
43
33
81
69
117
53
79
12
11
23
45
124
Cash Conversion Cycle
205
156
132
143
146
188
216
199
114
57
107
65
Working Capital Days
166
134
125
138
83
148
177
104
75
36
101
77
ROCE %
10%
10%
15%
17%
13%
7%
7%
9%
7%
8%
6%
12%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Chandra Bhagat Pharma insights

64 extracted metrics across FY15–FY26.

Shareholding Pattern

As of Sep 2026

  • Promoters 73.02%
  • Others 14.41%
  • Public 12.58%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Chandra Bhagat Pharma

What does Chandra Bhagat Pharma Ltd do?
Incorporated in 2003, Chandra Bhagat Pharma Ltd manufactures chemical and pharmaceutical products.
Where is Chandra Bhagat Pharma Ltd (CBPL) listed?
Chandra Bhagat Pharma Ltd trades under code 542934 on the BSE.
Which sector does Chandra Bhagat Pharma Ltd belong to?
Chandra Bhagat Pharma Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the 52-week high and low of Chandra Bhagat Pharma Ltd?
Over the last 52 weeks Chandra Bhagat Pharma Ltd has traded between ₹29.7 and ₹60.06 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Chandra Bhagat Pharma Ltd?
Chandra Bhagat Pharma Ltd reported a return on equity of 9.67%. Its debt-to-equity ratio is 0.50.

Company Information

Incorporated in 2003, Chandra Bhagat Pharma Ltd manufactures chemical and pharmaceutical products.

Website cbcpharma.com
CEO Mr. Hemant Chandravadan Bhagat
Employees 40
Listed 14 Feb 2020
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/542934.md for Chandra Bhagat Pharma Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month